 |
 Video: What is a Stock Split?
|
|
|
| Emergent BioSolutions is a life sciences company focused on providing a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). Co. is focused on products and solutions that address the following five distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives; emerging infectious diseases; travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). Co. has a product portfolio of ten marketed products (vaccines, therapeutics, and drug-device combination products). According to our EBS split history records, Emergent BioSolutions has had 0 splits. | |
|
Emergent BioSolutions (EBS) has 0 splits in our EBS split history database.
Looking at the EBS split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Emergent BioSolutions shares, starting with a $10,000 purchase of EBS, presented on a split-history-adjusted basis factoring in the complete EBS split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/17/2012 |
|
| End date: |
08/15/2022 |
|
| Start price/share: |
$15.50 |
|
| End price/share: |
$30.50 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
96.77% |
|
| Average Annual Total Return: |
7.00% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$19,671.51 |
|
| Years: |
10.00 |
|
|
|
|
|
